These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 34662777)

  • 1. Study protocol to assess polypharmacy and comorbidities in lung cancer.
    Pluchart H; Bailly S; Fauconnier J; Delafosse P; Chanoine S; Dumas I; Bedouch P; Toffart AC
    Respir Med Res; 2021 Nov; 80():100861. PubMed ID: 34662777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polypharmacy among older advanced lung cancer patients taking EGFR tyrosine kinase inhibitors.
    Hakozaki T; Matsuo T; Shimizu A; Ishihara Y; Hosomi Y
    J Geriatr Oncol; 2021 Jan; 12(1):64-71. PubMed ID: 32952094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polypharmacy as a prognostic factor in older patients with advanced non-small-cell lung cancer treated with anti-PD-1/PD-L1 antibody-based immunotherapy.
    Hakozaki T; Hosomi Y; Shimizu A; Kitadai R; Mirokuji K; Okuma Y
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2659-2668. PubMed ID: 32462298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentially inappropriate medication use in older patients with breast and colorectal cancer.
    Karuturi MS; Holmes HM; Lei X; Johnson M; Barcenas CH; Cantor SB; Gallick GE; Bast RC; Giordano SH
    Cancer; 2018 Jul; 124(14):3000-3007. PubMed ID: 29689595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with Cancer Receiving First-Line Palliative Chemotherapy.
    Hong S; Lee JH; Chun EK; Kim KI; Kim JW; Kim SH; Lee YG; Hwang IG; Kim JY; Koh SJ; Ko YH; Shin SH; Woo IS; Kim TY; Baek JY; Kim HJ; Kim HJ; Lee MA; Kwon JH; Hong YS; Ryoo HM; Kim JH
    Oncologist; 2020 Mar; 25(3):e502-e511. PubMed ID: 32162799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polypharmacy and comorbidities among ambulatory cancer patients: A cross-sectional retrospective study.
    Alwhaibi M; AlRuthia Y; Alhawassi TM; Almalag H; Alsalloum H; Balkhi B
    J Oncol Pharm Pract; 2020 Jul; 26(5):1052-1059. PubMed ID: 31619132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between polypharmacy and inpatient hospitalization among older adults with cancer treated with intravenous chemotherapy.
    Lu-Yao G; Nightingale G; Nikita N; Keith S; Gandhi K; Swartz K; Zinner R; Sharma S; Kelly WMK; Chapman A
    J Geriatr Oncol; 2020 May; 11(4):579-585. PubMed ID: 32199776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polypharmacy and hospitalization among older home care patients.
    Flaherty JH; Perry HM; Lynchard GS; Morley JE
    J Gerontol A Biol Sci Med Sci; 2000 Oct; 55(10):M554-9. PubMed ID: 11034227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentially inappropriate drug prescribing in elderly hospitalized patients: an analysis and comparison of explicit criteria.
    Di Giorgio C; Provenzani A; Polidori P
    Int J Clin Pharm; 2016 Apr; 38(2):462-8. PubMed ID: 26984238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of pretreatment comorbidities in elderly patients with advanced non-small-cell lung cancer treated with chemotherapy or epidermal growth factor receptor-tyrosine kinase inhibitor.
    Irisa K; Masago K; Togashi Y; Fujita S; Hatachi Y; Fukuhara A; Sakamori Y; Kim YH; Mio T; Mishima M
    Med Oncol; 2012 Mar; 29(1):185-92. PubMed ID: 21136210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of polypharmacy and drug interactions in patients with advanced cancer.
    Hoemme A; Barth H; Haschke M; Krähenbühl S; Strasser F; Lehner C; von Kameke A; Wälti T; Thürlimann B; Früh M; Driessen C; Joerger M
    Cancer Chemother Pharmacol; 2019 Apr; 83(4):763-774. PubMed ID: 30684020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management.
    Sokol KC; Knudsen JF; Li MM
    J Clin Pharm Ther; 2007 Apr; 32(2):169-75. PubMed ID: 17381667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of multidimensional comorbidities with survival, toxicity, and unplanned hospitalizations in older adults with metastatic colorectal cancer treated with chemotherapy.
    Kim KH; Lee JJ; Kim J; Zhou JM; Gomes F; Sehovic M; Extermann M
    J Geriatr Oncol; 2019 Sep; 10(5):733-741. PubMed ID: 30765268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do age and comorbidity impact treatment allocation and outcomes in limited stage small-cell lung cancer? a community-based population analysis.
    Ludbrook JJ; Truong PT; MacNeil MV; Lesperance M; Webber A; Joe H; Martins H; Lim J
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1321-30. PubMed ID: 12654444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of age, comorbidity, and polypharmacy on the efficacy and safety of edoxaban for the treatment of venous thromboembolism: An analysis of the randomized, double-blind Hokusai-VTE trial.
    Vanassche T; Verhamme P; Wells PS; Segers A; Ageno W; Brekelmans MPA; Chen CZ; Cohen AT; Grosso MA; Medina AP; Mercuri MF; Winters SM; Zhang G; Weitz JI; Raskob GE; Büller HR
    Thromb Res; 2018 Feb; 162():7-14. PubMed ID: 29248859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polypharmacy and potentially inappropriate medication use in older adults with cancer undergoing chemotherapy: effect on chemotherapy-related toxicity and hospitalization during treatment.
    Maggiore RJ; Dale W; Gross CP; Feng T; Tew WP; Mohile SG; Owusu C; Klepin HD; Lichtman SM; Gajra A; Ramani R; Katheria V; Zavala L; Hurria A;
    J Am Geriatr Soc; 2014 Aug; 62(8):1505-12. PubMed ID: 25041361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis.
    Oda K; Yatera K; Fujino Y; Kido T; Hanaka T; Sennari K; Fushimi K; Matsuda S; Mukae H
    Respir Investig; 2018 Jan; 56(1):64-71. PubMed ID: 29325684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe drug interactions and potentially inappropriate medication usage in elderly cancer patients.
    Alkan A; Yaşar A; Karcı E; Köksoy EB; Ürün M; Şenler FÇ; Ürün Y; Tuncay G; Ergün H; Akbulut H
    Support Care Cancer; 2017 Jan; 25(1):229-236. PubMed ID: 27619388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and Risk of Polypharmacy Among Elderly Cancer Patients Receiving Chemotherapy in Ambulatory Oncology Setting.
    Goh I; Lai O; Chew L
    Curr Oncol Rep; 2018 Mar; 20(5):38. PubMed ID: 29582192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Unplanned Hospitalizations in Patients With Nonmetastatic Lung Cancer During Chemotherapy.
    Fessele KL; Hayat MJ; Atkins RL
    Oncol Nurs Forum; 2017 Sep; 44(5):E203-E212. PubMed ID: 28820513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.